USD23.22
mg:20 https://framerusercontent.com/images/zBlLjlfBxsFJTJt0oS0XkgAWM.png [2] [11] As of 2026, retatrutide has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA), and it remains an experimental compound available only within authorised clinical trial settings CODE_BOGO50_SEP26 How To Give A Subcutaneous Injection And Sites - The HCG Institute
USD23.22
USD23.00
USD26.79
USD28.09
USD28.07
USD24.42